Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Mark J. Smyth, Jake S. O’Donnell et al.|Clinical Cancer Research|2020Cited by 113